News tagged with drug companies

Personalizing targeted immunotherapy

This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are approved for a variety of cancers, as forecast recently by Drew Pardoll, MD, PhD, in a blog post. There is huge excitement surrounding these drugs because patients with nume ...

Apr 30, 2015
popularity 5 comments 0